Literature DB >> 4540994

The origin of pandemic influenza.

R G Webster, W G Laver.   

Abstract

Serological tests, using antisera specific to the surface subunits of the viruses (e.g., antisera to the haemagglutinin subunits devoid of any antineuraminidase or anti-host antigen activity) showed that the haemagglutinin subunits of the Hong Kong virus were, immunologically, distinct from the subunits of the preceding A/Asian strains. On the other hand, the neuraminidase subunits of the Hong Kong virus are related to those of the A/Asian strains. The haemagglutinin subunits of influenzaviruses are composed of two pairs of light and heavy polypeptide chains and it was found that the amino acid sequence of the light and heavy chains from the haemagglutinin subunits of the Hong Kong virus differed remarkably from those of the preceding A/Asian strains. These findings suggest that Hong Kong virus did not arise by mutation from a pre-existing human strain and that it probably arose by the selection of a genetic recombinant in a partially immune population. It is postulated that the recombinant was formed as the result of the mixed infection of an animal or bird with an animal or avian influenzavirus and a human A/Asian strain. The animal (or avian) virus could have donated the haemagglutinin subunits of A/Hong Kong/1/68 virus and the neuraminidase subunits could have come from the human A/Asian strain.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4540994      PMCID: PMC2480853     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  20 in total

Review 1.  Reverse zoonosis of influenza to swine: new perspectives on the human-animal interface.

Authors:  Martha I Nelson; Amy L Vincent
Journal:  Trends Microbiol       Date:  2015-01-04       Impact factor: 17.079

2.  Sources of influenza.

Authors: 
Journal:  Br Med J       Date:  1973-06-30

3.  Association between influenza during pregnancy and childhood leukaemia.

Authors:  T Hakulinen; L Hovi; K Penttinen; L Saxén
Journal:  Br Med J       Date:  1973-11-03

4.  Wild ducks are the reservoir for only a limited number of influenza A subtypes.

Authors:  G B Sharp; Y Kawaoka; S M Wright; B Turner; V Hinshaw; R G Webster
Journal:  Epidemiol Infect       Date:  1993-02       Impact factor: 2.451

5.  The WHO programme for virus diseases in relation to recent trends in medical virology.

Authors:  P Brès
Journal:  Experientia       Date:  1977-01-15

6.  An epidemiological study of influenza viruses among Chinese farm families with household ducks and pigs.

Authors:  L L Shu; N N Zhou; G B Sharp; S Q He; T J Zhang; W W Zou; R G Webster
Journal:  Epidemiol Infect       Date:  1996-08       Impact factor: 2.451

7.  A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus.

Authors:  Yu-Na Lee; Young-Tae Lee; Min-Chul Kim; Andrew T Gewirtz; Sang-Moo Kang
Journal:  J Immunol       Date:  2016-02-10       Impact factor: 5.422

8.  Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates.

Authors:  Y P Lin; M Shaw; V Gregory; K Cameron; W Lim; A Klimov; K Subbarao; Y Guan; S Krauss; K Shortridge; R Webster; N Cox; A Hay
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

9.  PB2 protein of a highly pathogenic avian influenza virus strain A/chicken/Yamaguchi/7/2004 (H5N1) determines its replication potential in pigs.

Authors:  Rashid Manzoor; Yoshihiro Sakoda; Naoki Nomura; Yoshimi Tsuda; Hiroichi Ozaki; Masatoshi Okamatsu; Hiroshi Kida
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

10.  Reassortment between avian H5N1 and human H3N2 influenza viruses in ferrets: a public health risk assessment.

Authors:  Sara Jackson; Neal Van Hoeven; Li-Mei Chen; Taronna R Maines; Nancy J Cox; Jacqueline M Katz; Ruben O Donis
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.